ACSL4 and cancer: A role for long-chain fatty acid activating enzymes in supporting the malignant phenotype was first suggested in 2000 when Cao et al. [27] asserted that ACSL4 could promote carcinogenesis by lowering the levels of unesterified AA, thus inhibiting AA-mediated apoptosis in cancer cells.